Headline

CDC releases COVID-19 guidance for those with health conditions

Elle Johnson | Jan 10, 2021

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

The Centers for Disease Control and Prevention (CDC) said those with preexisting health conditions are more at risk of severe illness if they contract COVID-19.

Featured

The U.S. Food and Drug Administration approved the first drug to be used for positron emissions tomography imaging for prostate cancer.

Regulatory FDA approves drug for PET scanning for prostate cancer patients Dec 4, 2020

Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region.

Regulatory Southeast Asian nations may prefer China over U.S., RAND study finds Dec 2, 2020

Amazon has now launched an online pharmacy to serve as competition for other big-named retail pharmacies.

Industry Amazon opens online pharmacy Nov 21, 2020

All dispensers, such as pharmacies, will have to meet requirements that go into effect Friday, Nov. 27.

Industry APhA urges the FDA to delay DSCSA requirements Nov 11, 2020

Latest News

Sklice is now an over-the-counter treatment for head lice.

Innovation FDA approves over-the-counter head lice lotion Oct 30, 2020

The U.S. Food and Drug Administration recently issued a Drug Safety Communication requiring a labeling change on some over-the-counter pain medications for pregnant women past 20 weeks.

Industry FDA issues warning for pregnant women who take some pain, fever medications after 20 weeks Oct 25, 2020

Pharmacists may qualify for student loan repayment through a two-year research program.

Innovation Pharmacists may qualify for NIH student loan repayments up to $100,000 Oct 20, 2020

The FDA approved the use of Opdivo and Yervoy to treat mesothelioma.

Innovation FDA approves drug combination that treats mesothelioma Oct 8, 2020

The FDA approved the use of Pfizer's drug XELJANZ on children over two years old with polyarticular course juvenile idiopathic arthritis.

Innovation FDA approves use of XELJANZ on children Oct 3, 2020

A phase three trial of a new cancer drug from Eli Lilly showed 25% reduced risk of recurrence for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative high risk early breast cancer.

Innovation Trial shows promise for Eli Lilly-developed breast cancer treatment Sep 23, 2020



People

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Innovation

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory

CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry

NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Federal Issues

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

State Issues

States are using the health care system to help people suffering from opioid use disorder.

States are using the health care system to battle opioid use disorder Jul 27, 2020

Trending

APHA: Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine